| abstract |
The invention relates to the technical field of chemical medicine, and specifically discloses a 2-oxo-1,2-dihydrobenzo[cd]indole compound. The compounds of the present invention and their pharmaceutically acceptable salts, isomers, racemates, prodrugs, co-crystal complexes, hydrates and solvates can effectively inhibit the BET bromodomain receptor and can be used for preparing Drugs for the treatment of cancer, cell proliferation disorders, inflammatory and autoimmune diseases, sepsis, viral infections. |